The New Era of Funding Innovation in Women’s Health

This is a story about what happens when life sciences leaders and experienced fund managers with a cumulative $60 billion in AUM decide to come together to systematically change how women's health innovation is funded. Conceptualized in partnership with industry heavyweights, this innovative approach aims to activate capital allocation into a space that has been historically under-recognized, under-funded, and under-prioritized to the detriment of half the population. The economic case is staggering: McKinsey Health Institute research shows that closing the women's health gap could regain 75 million years of lost life and unlock at least a $1 trillion annual global economic opportunity by 2040. This isn't charity or impact investing for good PR, it's experienced investors recognizing that the women's health market represents one of the largest untapped opportunities in healthcare, with fundamental gaps in medical knowledge creating white space for innovation that could generate both significant returns and transformative health outcomes.